21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Methods of using cytokine zalpha11 ligand
#20102Use of Insulin for the Treatment of Cartilaginous Disorders
#20103CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#20104Growth factor homolog ZVEGF4
#20105Growth factor homolog zvegf4
#20106Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#20107Anti-inflammatory compositions and personal care compositions comprising olive leaf () extract
#20108Anti-inflammatory compositions and methods of use
#20109Antibacterial treatment and composition
#20110Topical turmeric skin care products
#20111Plant extract mixtures and their uses
#20112Tissue disruption treatment and composition for use thereof
#20113MEDICAMENT FOR TREATING INFLAMMATORY AND NON-INFLAMMATORY ARTHRITIS
#20114Methods for promoting growth of bone, ligament, and cartilage
#20115Herbal composition for treating morning sickness
#20116Synthetic nutritional formulations
#20117Combination therapy of peptide vaccination and estramustine treatment
#20118Methods for treating pain and hyperhidrosis
#20119Combination therapies for inhibiting integrin-extracellular matrix interactions
#20120Method of treating fibroproliferative disorders
#20121METHOD OF REDUCING PROLIFERATION OF CELLS IN A MAMMAL
#20122Method for generating anti-variable region monoclonal antibodies
#20123Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation
#20124Method for preparing alginate capsules
#20125Cardiac arrhythmia treatment methods
#20126HCV COMBINATION THERAPY
#20127METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY
#20128Cytokine zalpha11 ligand fusion proteins
#20129Method of use of cytokine ZALPHA11 ligand
#20130Method for treatment of demyelinating central nervous system disease
#20131GENERATION OF DENDRITIC CELLS
#20132Methods of treating concomitant constipation in a cancer treatment regimen including imexon
#20133Novel skin care compositions
#20134Cosmetic composition to accelerate repair of functional wrinkles
#20135Cosmetic composition for cleaning the skin
#20136Anti-aging composition containing criste marine and padina pavonica extracts
#20137COMPOSITIONS AND METHODS FOR TREATING ACNE
#20138Buccal, polar and non-polar spray containing atropine
#20139Antibody fragment-polymer conjugates and uses of same
#20140Therapeutic combination for painful medical conditions
#20141Method for preventing and/or treating neurodegenerative diseases
#20142Use of non-opiates for the potentation of opiates
#20143Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins
#20144Alpha-lipoic acid concentrate
#20145Medicaments containing famotidine and ibuprofen and administration of same
#20146Unit dose form with ibuprofen-famotidine admixture
#20147Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis
#20148Weak base salts
#20149Dihydropteridinones in the treatment of respiratory diseases
#20150Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes
#20151Reverse-turn mimetics and method relating thereto
#20152Chlorine Ion Uptake Modulators and Uses Thereof
#20153Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist
#20154Methods to enhance chemotherapy
#20155Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
#20156TREATMENT OF HYPERPROLIFERATIVE DISEASES USING HIGH DOSES OF ACTIVE VITAMIN D
#20157Immunosuppresive effects of pteridine derivatives
#20158Medical cosmetic method for reducing adipose tissue and for initiating lipolysis through subcutaneous and intracutaneous injections and customized composition compounded from pharmaceutical agents for use therein
#20159Modified 2′ and 3′-nucleoside prodrugs for treating infections
#201602' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#20161Treatment of pain and fever
#20162Compositions and methods for optimizing exercise recovery
#20163TYPE V PHOSPHODIESTERASE INHIBITORS AND NATRIURETIC POLYPEPTIDES
#20164Antiepileptogenic complex of albumin with docosahexaenoate
#20165Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides
#20166Cyclosporin galenic forms
#20167Modified 2′ and 3′-nucleoside prodrugs for treating infections
#20168Modified 2′ and 3′-nucleoside prodrugs for treating infections
#20169Sequences facilitating penetration of a substance of interest
#20170Treatment of Alzheimer's Disease
#20171Binding molecules capable of neutralizing west nile virus and uses thereof
#20172Protein kinase modulation by hops and products
#20173Novel anti-diabetic herbal formulation
#20174Methods to treat one or all of the defined etiologies of female sexual Dysfunction
#20175Methods for modulating eicosanoid metabolism
#20176Delivery system for appetite suppressant
#20177Compositions for the treatment and prevention of diabetes mellitus
#20178Anti-stress agent
#20179Herbal formulations and cigarettes containing same useful in controlling body weight
#20180FUNCTIONAL APHRODISIAC ROLLED HERBAL BIDIS AND CIGARETTES
#20181Medicinal herbal composition for treating infection
#20182Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression
#20183Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#20184Methods and compositions using gonadotropin hormone releasing hormone
#20185Pharmaceutical composition containing levodopa and carbidopa
#20186Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
#20187Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein
#20188Combination of a serotonin reuptake inhibitor and loxapine
#20189Topical composition for delivery of salicylates
#20190Compositions containing phosphatidylcholine and essential fatty acids
#20191Topical composition for delivery of salicylate esters
#20192Compositions and methods for treating prostate disorders
#20193Compositions and methods for symptomatic relief
#20194Compositions and methods for inactivating or suppressing inflammatory cells
#20195CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#20196Vaccine immunotherapy for immune suppressed patients
#20197Hedgehog signaling promotes the formation of three dimensional cartilage matrices
#20198NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#20199Modified cytokines for use in cancer therapy
#20200Bone substitute composition
#20201Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
#20202Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
#20203Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
#20204Anticancer composition comprising obovatol or obovatal
#20205Blockade of mtor to prevent a hormonal adaptive response
#20206Bone marrow erythroid progenitor cell(s) differentiation inducer
#20207Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
#20208Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
#20209Enhanced method of treatment of growth disorders
#20210Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
#20211Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
#20212Migrastatin analogs and uses thereof
#20213Treatment of neurological conditions
#20214Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid
#20215Compositions and methods for inhibiting neurodegeneration
#20216Methods of using PDE 5 inhibitors for the treatment of congestive heart failure
#20217Enhancing the effect of radioimmunotherapy in the treatment of tumors
#20218Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events
#20219Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
#20220Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
#20221Pyrazolidinol compounds
#20222Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
#20223Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis
#20224Compounds useful in coating stents to prevent and treat stenosis and restenosis
#20225Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions
#20226Composition and method for the repair and regeneration of cartilage and other tissues
#202272' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#20228Molecules that block viral infectivity and methods of use thereof
#20229Injectable capsaicin
#20230Compositions and methods for controlling glucose and lipid uptake from foods
#20231Method of treatment or management of stress
#20232Aiding of cognitive function
#20233Methods for prophylactic and therapeutic nutritional supplementation
#20234Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof
#20235Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin
#20236Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
#20237Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
#20238Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
#20239Seaweed extract composition for retardation of cardiovascular disorders and preservation of healthy cardiovascular function
#20240Method and composition for reconforming multi-epitopic antigens to initiate an immune response
#20241Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist
#20242TREATMENT WITH ANTI-VEGF ANTIBODIES
#20243Tissue graft composition comprising autologous bone marrow and purified autologous thrombin
#20244TREATMENT WITH ANTI-VEGF ANTIBODIES
#20245TREATMENT WITH ANTI-VEGF ANTIBODIES
#20246TREATMENT WITH ANTI-VEGF ANTIBODIES
#20247Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
#20248Activation of Egr-1 promoter by DNA damaging chemotherapeutics
#20249Pharmaceutical combination useful for stem cell mobilization
#20250Treatment or prevention of respiratory viral infections with alpha thymosin peptides
#20251Methods and compositions for modulating hair growth or regrowth
#20252PRODUCTS FOR TOPICAL APPLICATION COMPRISING LYSOPHOSPHOLIPIDS AND FATTY ACIDS
#20253Stable topiramate formulations
#20254Prostate cancer diagnosis and treatment
#20255Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
#20256Formulations comprising fenofibrate and a statin, and related methods of treatment
#202575-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases
#20258Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration
#20259Pyrimidine compounds as serotonin receptor modulators
#20260Treatment of ischemia-induced arrhythmias
#20261Method for treating hyperlipidemia
#20262Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha
#20263Combination therapy for cancer treatment
#20264ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS
#20265New compositions and methods for the treatment of inflammation
#20266Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
#20267Antimicrobial agents
#20268Compositions for diabetes treatment and prophylaxis
#20269Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
#20270METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
#20271Treating diabetes with glucagon-like peptide-1 secretagogues
#20272Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same
#20273Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
#20274Methods for treating diabetes and related disorders using pde10a inhibitors
#20275Oxygen Indicator for Use in Medical Products
#20276Infant or follow-on formula
#20277Synergistic composition for the treatment of diabetes mellitus
#20278Cytokine modulators and related methods of use
#20279Composition for the prevention and treatment of cellulitis
#20280Carbostyril derivatives and mood stabilizers for treating mood disorders
#20281Method of treatment
#20282Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto
#20283Breakthrough to cure psoriasis, psoriatic arthritis and treatment of other unrelated skin disorders, and external rectal and genital itching
#20284Gastric acid secretion inhibiting composition
#20285Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
#20286Nutritional supplement for use under physiologically stressful conditions
#20287Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)
#20288Steroid-containing sustained release intraocular implants and related methods
#20289Powder exfoliating compositions and methods for producing the same
#20290TREATMENT WITH ANTI-VEGF ANTIBODIES
#20291Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
#20292Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs
#20293One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose
#20294Compositions and methods for enhancing axon regeneration
#20295Neural stem cells and use thereof for brain tumor therapy
#20296Apparatus and method to treat a wound area
#20297Recombinant adenoviral vector and method of use
#20298Antibodies against IL-16 antagonist peptides
#20299Combination therapy
#20300Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors
#20301Vaccine immunotherapy for immune suppressed patients
#20302Composition and method for neck skin firming
#20303Keratin gel and the types 2,4 and 6 of collagens of frog protein topical use or for lamina preparation use, such as dressing powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical
#20304Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate
#20305Methods of delivering therapeutics to the brain
#20306Multiple chamber container
#20307Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15
#20308Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof
#20309Method of treating inflammatory arthritis
#20310Use of progesterone receptor modulators
#20311Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers
#20312Novel compositions comprising higher primary alcohols and nicottinic acid and process of preparation thereof
#20313Compositions for veterinary and medical applications
#20314Antineoplastic activities of ellipticine and its derivatives
#20315Crystalline pharmaceutical
#20316XIAP-targeted prostate cancer therapy
#20317Tricyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic
#20318Treatment of inflammatory oral diseases with a combination of inhibitors of TNF-alpha and immunosuppressive agents
#20319Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#20320Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#20321Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#20322Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
#20323Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#20324Anorectic
#20325Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2
#20326Method for treatment of vitiligo
#20327Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptides
#20328Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
#20329Modified 2′ and 3′-nucleoside prodrugs for treating infections
#20330Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#20331Methods for reducing viral load in HIV-1-infected patients
#20332Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer
#20333Pharmaceutical Antidiabetic Composition
#20334Antimicrobial and antiviral composition
#20335Transdermal pharmaceutical preparation containing active substance combinations, for treating Parkinson's disease
#20336Reinforced matrices
#20337Use of VEGF For Treating Bone Defects
#20338Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
#20339Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant
#20340Interferon beta in severe acute respiratory syndrome (sars)
#20341APO-2 ligand-anti-her-2 antibody synergism
#20342APO-2L receptor agonist and CPT-11 synergism
#20343TREATMENT WITH ANTI-VEGF ANTIBODIES
#20344METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY
#20345Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
#20346Method for Treating Lupus
#20347Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses
#20348HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
#20349Vaccine immunotherapy
#20350Vascular targeting of ocular neovascularization
#20351Co-therapy for diabetic conditions
#20352COMPOSITION AND METHOD FOR TREATING CELLULITE
#20353Photoprotector and/or photoimmunoprotector compositions of the skin and their uses
#20354ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES
#20355Method of attenuating neurogenic swelling or neurogenic inflammation
#20356Method of attenuating swelling or inflammation
#20357Method of attenuating neurogenic pain
#20358Systems and methods for delivery of a therapeutic agent
#20359Anticancer therapy
#20360Apparatus for automatically feeding the silver wire into the solution
#20361Method for the production of an agent from larvae in flies for treating wounds and agent produced according to said method
#20362Treatment of leg ulcers using placenta derived collagen biofabric
#20363System and method for use of agent in combination with subatmospheric tissue treatment
#20364Phosphate transport inhibitors
#20365Method for treatment of Helicobacter pylori infection and/or an associated disease
#20366Prevention and treatment of ophthalmic complications of diabetes
#20367Methods of treating epileptogenesis
#20368Methods for neuroprotection
#20369VITAMIN E COMPOSITIONS
#20370Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
#20371Compositions for reducing the incidence of drug induced arrhythmia
#20372Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
#20373Heparin compositions and selectin inhibition
#20374Pharmaceutical composition comprising a macrolide immunomodulator
#20375Supplement composition and method of use in enhancement of methylation process
#20376Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
#20377Treatment of inflammatory conditions
#20378PREVENTION AND TREATMENT OF HEARING DISORDERS
#20379Use of blood coagulation factor XIII for treating hemophilia A
#20380GLP-1 pharmaceutical compositions
#20381Pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins
#20382Composition and its Therapeutic Use
#20383Diaryl ureas with kinase inhibiting activity
#20384Treatment modalities for autoimmune diseases
#20385Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them
#20386Composition for treating hepatitis C
#20387Bioavailability enhancing activity of Carum carvi extracts and fractions thereof
#20388Botanical anticancer formulations
#20389Nutrient supplements and methods for treating autism and for preventing the onset of autism
#20390Non-irritating compositions containing zinc salts
#20391Method for preparing peritoneal dialysate
#20392Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension
#20393Tannate compositions, methods of making and methods of use
#20394Compositions comprising azelastine and methods of use thereof
#20395Wound dressing and methods of making and using the same
#20396Composition of amylase inhibitors and fibers to reduce the absorption of starch in human digestion from starchy foods, and to reduce the glycemic index of starchy foods
#20397Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
#20398Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
#20399System and method for the treatment of cancer, including cancers of the central nervous system
#20400Mycoplasma hyopneumoniae bacterin vaccine